StephanieSchaubMD

Our own @SchaubMD @uwradonc and CNS/ spine legend @SahgalArjun @Sunnybrook @UofTDRO ! Don’t miss this webinar! @joshuapalmermd @Hofstetter_MD @UWNeurosurgery

We want to recognize some of the #SurgicalOncologist that support the #Sarcoma community. Thank you for the work you do! #SurgicalOncologistDay #dragonslayersunite

@uwradonc @UWNeurosurgery @fredhutch @KristinRedmond2 @hopkinskimmel @ANViswanathanMD @SchaubMD @DrFehlings @uoftmedicine @MSK_RadOnc

@MacklinNguyenMD @uwradonc @HyperX I have to test yours out sometime!

My plan is working. Slowly convincing our @UWRadOnc nurses 🩺☤ to convert to @HyperX mechanical keyboards to make the charting experience more tolerable 🙃😁 #nurses #radonc #mechanicalkeyboard #residentlife

Interesting study from #MDACC I use this regimen for radioresistant osseous #metastases too extensive for #spine #SBRT #IMRT #roedu #radonc sciencedirect.com/science/articl…

Important perspectives Maybe this is something @nwsarcoma and @OHSUKnight and @fredhutch can parter on: improving our efforts to include #sarcoma patient perspectives in our research

Thurs, Jan. 26, learn about Proton Therapy by Dr. Stephanie Schaub with @fredhutch and how it may be used as a form of targeted radiation therapy for Sarcoma patients. #nwsarcoma, #dragonslayersunite, #fredhutch

Nearly All Oncology Providers Report Prior Authorization Causing Delayed Care, Other Patient Harms | ASCO old-prod.asco.org/news-initiativ…

Just a fraction of the #wewhocurie in our department @uwradonc @fredhutch Honored to work with @ebadimary1 @havard_molly @SchaubMD @ErinGillespieMD @VictoriaNoelleB @WomanPhysicist @JingZeng98195 @SaraZakem @EmilyWegMD and many others!

Effective hypofractionated radiation (42.75 Gy in 15 frac) for treatment of soft tissue sarcomas. Congrats to ⁦⁦⁦@ashleighg⁩ and ⁦@MDAndersonNews⁩ #radonc colleagues. #ASTRO22 #endcancer

@fredhutch And we’re hiring in sarcoma (and other cancer types)! Exciting opportunities to advance cancer treatment and improve lives for patients here in Seattle.

#ChildhoodCancerAwarenessMonth, we're highlighting a #pediatric #radonc study on mutational burden in #EwingSarcoma by @DHaasKogan @kevinxliu @NayanLamba @DrWilliamHwang @BrighamRadOnc @DFBC_PedCare @HarvardRadOnc Check out their work at acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #GoGoldForKids 🎗️

Beautiful morning to dragon slay. #NWSarcomaFoundation walk. Thank you for all that you do to support our patients!

SBRT for oligometastatic sarcoma: results from our phase II trial confirming high rates of LC with negligible toxicity. sciencedirect.com/science/articl…

This is so important, particularly as a provider caring for rare diseases. nejm.org/doi/full/10.10…

West Coast Sarcoma Conference in Seattle this weekend! ⁦Looking forward to good discussions about #sarcoma science and advances @fredhutch⁩ ⁦@SeattleCCA⁩ ⁦@UWMedicine⁩

@uwradonc @IUradonc @RadoncUh @BeaumontRadOnc @QueensRadOnc @Sunnybrook @PeterMacRadOnc @AncaGrosu1 @CZamboglou @SE_Combs @KristinRedmond2 @MayoRadOnc @KenOlivierMD @DrStish @_ShankarSiva @TimkWin @emmadunne @matt_footy @subatomicdoc @SchaubMD

This article from our @BTFjournal discusses sarcoma specific considerations for academic-community partnerships across the cancer care spectrum and how these relationships have been impacted by the COVID-19 pandemic. @wagsmd @SchaubMD journal.binayfoundation.org/article/32477-…